Literature DB >> 17610277

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome.

Onpan Cheung1, Ashwani Kapoor, Puneet Puri, Sakita Sistrun, Velimir A Luketic, Carol C Sargeant, Melissa J Contos, Mitchell L Shiffman, Richard T Stravitz, Richard K Sterling, Arun J Sanyal.   

Abstract

UNLABELLED: The patterns of fat distribution and their relationship to severity of nonalcoholic fatty liver disease (NAFLD) are unknown. The objectives of this study were to define the fat distribution patterns and their relationship to histological severity and metabolic parameters in subjects with NAFLD. Anthropometric indices and total body fat were measured in 123 subjects. Fat distribution patterns were defined as: general, abdominal, limb, truncal, and dorsocervical lipohypertrophy (DCL) a novel finding in NAFLD. Eighty-one (66%) of the subjects were obese, and 94 (76%) had abdominal obesity. Thirty-five (28.5%) had DCL. Whereas body mass index (BMI) correlated best with the presence of diabetes (r = 0.22, P < 0.05), waist circumference (WC) correlated best with hypertension (r = 0.2, P < 0.05), hypertriglyceridemia (r = 0.37, P < 0.001), and insulin resistance (homeostasis model of assessment for insulin resistance [r = 0.68, P < 0.0001]). None of the patterns of fat distribution were significantly associated with severity of hepatic steatosis. Abdominal obesity (WC) correlated with inflammation (r = 0.2, P < 0.05) only. DCL correlated significantly with the severity of all histological parameters except steatosis. Whereas DCL was the single greatest contributor to the variability in severity of histological parameters, a model combining BMI, WC, and DCL showed the greatest contribution to the variability in severity of individual histological parameters. The addition of steatosis grade to the model significantly increased its contribution to the range of lobular inflammation.
CONCLUSION: WC predicts metabolic risk profile with the most significance. However, DCL is most strongly associated with severity of steatohepatitis. WC and BMI added modestly to the contribution of DCL to severity of nonalcoholic steatohepatitis.

Entities:  

Mesh:

Year:  2007        PMID: 17610277     DOI: 10.1002/hep.21803

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  Hüseyin Saadettin Uslusoy; Selim Giray Nak; Macit Gülten
Journal:  World J Hepatol       Date:  2011-08-27

2.  Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Aynur Unalp-Arida; Katherine Yates; Arun Sanyal; Cynthia Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

Review 3.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

4.  The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

Authors:  Sombat Treeprasertsuk; Scott Leverage; Leon A Adams; Keith D Lindor; Jennifer St Sauver; Paul Angulo
Journal:  Liver Int       Date:  2012-02-02       Impact factor: 5.828

5.  Trunk fat as a determinant of liver disease.

Authors:  Jacquelyn J Maher
Journal:  Gastroenterology       Date:  2010-02-23       Impact factor: 22.682

6.  Differential effect of gender on hepatic fat.

Authors:  Vicente Gilsanz; Sandra A Chung; Neil Kaplowitz
Journal:  Pediatr Radiol       Date:  2011-03-15

7.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

8.  Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases.

Authors:  Akiko Eguchi; Ariel E Feldstein
Journal:  Liver Res       Date:  2018-02-28

9.  Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat.

Authors:  Hua Zhang; Yuanwu Liu; Li Wang; Zhen Li; Hongwen Zhang; Jihua Wu; Nafis Rahman; Yangdong Guo; Defa Li; Ning Li; Ilpo Huhtaniemi; Suk Ying Tsang; George F Gao; Xiangdong Li
Journal:  J Lipid Res       Date:  2012-11-21       Impact factor: 5.922

10.  Nonalcoholic fatty liver disease and cardiovascular risk.

Authors:  Vijay Laxmi Misra; Mouen Khashab; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.